Gloucestershire Health and Care- NHS Trust logo
with you, for you
Archive for Clinical Activity Data

Search for a reference number

Clinical Activity Data

Non-British patients

,

Dear FOI Team,

I am writing to obtain information about the number of non-British citizens treated by your trust. Please include the following for the previous 3 financial years (2022-23, 2023-24 and 2024-25) :

• The total number of non-British citizens treated in the previous 3 financial years.
• The total cost of treating those patients
• The total amount recovered from those patients
• The total number of adults treated who did not have a NHS number in the previous 3 financial years
• The total cost of treating those patients
• The total amount recovered from those patients

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
If you have any queries please do not hesitate to contact me.

Best wishes,

read more

Dravet Syndrome and Lennox-Gastaut Syndrome

Dear FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Where possible, I would be grateful if the requested data could be provided in an editable format (e.g. .xlsx or .csv). If this is not feasible, a table format would also be acceptable, and example layouts are suggested below for reference.

For all questions, patient numbers should represent unique patients within the specified reporting period. Where a monthly breakdown is not available, please provide unique patient numbers aggregated by quarter instead. If the tables below are not showing correctly due to formatting issues, then please let me know and I can send them in a word document.

Priority questions:

1. The number of patients under the trust’s care with a recorded diagnosis of Dravet syndrome in each month of 2025 (January–December). Patients may be counted in more than one month. Likely coded as ICD-10 code G40.3 or SNOMED code 230437002.
a. Patient numbers segmented by age:
i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ 2. The number of patients under the trust’s care with a recorded diagnosis of Lennox-Gastaut syndrome in each month of 2025 (January-December). Patients may be counted in more than one month. Likely coded as ICD-10 code G40.4 or SNOMED code of 230418006. a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ Example table for Q1 & 2: Age/Month Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 <2 years old 2-8 years old 9-17 years old 18+ years old 3. The number of patients under the trust’s care who have been treated with fenfluramine in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 Example table for 3 – 12 a)i – b)ii Age group / Month Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 Jul-25 Aug-25 Sep-25 Oct-25 Nov-25 Dec-25 <2 years Total patients Dravet syndrome Lennox–Gastaut syndrome 2-8 years Total patients Dravet syndrome Lennox–Gastaut syndrome 9-17 years Total patients Dravet syndrome Lennox–Gastaut syndrome 18+ years Total patients Dravet syndrome Lennox–Gastaut syndrome c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 4. The number of patients under the trust’s care who have been treated with cannabidiol in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 5. The number of patients under the trust’s care who have been treated with cenobamate in in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 6. The number of patients under the trust’s care who have been treated with rufinamide in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 7. The number of patients under the trust’s care who have been treated with stiripentol in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. Good to know questions: 8. The number of patients under the trust’s care who have been treated with clobazam in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 9. The number of patients under the trust’s care who have been treated with sodium valproate in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 10. The number of patients under the trust’s care who have been treated with topiramate in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002 ii. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Dravet syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication d. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. 11. The number of patients under the trust’s care who have been treated with lamotrigine in 2025 (January-December), separated by month a. Patient numbers segmented by age: i. <2 years old ii. 2-8 years old iii. 9-17 years old iv. 18 years+ b. For these patients, how many of them had a diagnosis of: i. Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006 c. For patients with a recorded diagnosis of Lennox–Gastaut syndrome treated with fenfluramine during 2025, please indicate which other anti-seizure medications were recorded for these patients during the year, and the number of patients associated with each medication. Many thanks,

read more

Clinical Activity Data / Finance – Asylum Seekers

,

Dear FOl Officer,

Under the Freedom of lnfom1ation Act 2000, I request the following information for the financial years 2022/23, 2023/24 and 2024/25:

1. The total number of patient episodes (e.g., emergency, inpatient, outpatient) recorded in your trust’s systems where the patient was flagged as an asylum seeker or exempt from charging due to asylwn/refugee status.

2. Total NHS expenditure associated with those episodes, by category where available (e.g., by service type such as A&E, inpatient, outpatient, prescriptions, maternity).

3. Whether your trust records immigration status or charging exemption codes that can distinguish asylum seekers from other charging exemption categories.

Please provide this information in a machine-readable format (e.g., CSV or Excel) where possible.

If you believe supplying the financial cost data would exceed the appropriate cost limit, please provide the patient episode counts and, separately, any average cost figures you can supply.

I confirm that I am requesting this information under the Freedom of Information Act, and I look forward to your response within 20 working days.

Yours sincerely,

read more

Hospital Data (ICD-10)

Dear Sir or Madam,

I am writing to make a request under the Freedom of Information act

I am seeking hospital-level activity data within your health authority, as outlined below.

Dataset 1: ICD-10 Diagnosis Data

For each hospital, please provide:
• From 2022 up to the latest data available, preferably by calendar year
• Primary (first) diagnosis ICD-10 codes (three or more characters), chapters A–Q only, including patients outsourced to the private sector
• Number of cases per ICD-10 code
• Hospital name and postcode

Dataset 2: Procedures / Surgery Data

For each hospital, please provide:
• Years: 2020 up to and including 2024, preferably by calendar year
• Primary procedure OPCS codes, all chapters, including patients outsourced to the private sector
• Number of cases per OPCS code
• Hospital name and postcode

With regard to case numbers for both ICD-10 and OPCS data, we recognise that disclosure controls may apply where case numbers are fewer than five. In such instances, please indicate the value as “<5” or similar format, depending on your small-case policy. We would be grateful if the data could be provided in a machine-readable format (for example, CSV or Excel), if possible. For context, we already hold comparable datasets for most European countries. This information is collected and processed for research and pharmaceutical organisations, where it is used for market analysis and clinical trial planning. We hope this explains the purpose and potential value of supplying the requested data. Please let us know if any clarification is required. I look forward to hearing from you.

read more

Patients Awaiting Initial Assessment-Memory Clinics-Suspected Dementia

, ,

Dear Sir/Madam, Under the Freedom of Information Act 2000, I would like to request the following information relating to waiting lists and waiting times for patients awaiting an initial assessment at memory clinics for suspected dementia:

1. Waiting List Size

o The number of patients currently on the waiting list for an initial memory clinic assessment for suspected dementia, as of the most recent available date.

2. Waiting Times

o The average waiting time (in weeks and/or days) from referral to first assessment at your memory clinic for suspected dementia for the most recent reporting period.
o The median waiting time (if available).
o The range of waiting times (shortest and longest) for patients currently on the waiting list.

3. Historical Data

o The waiting list size and average waiting time for the same service for each quarter over the last 12 months (e.g., Q1, Q2, Q3, Q4).

4. Referral and Assessment Source Data

o The number of referrals received in the last 12 months for memory clinic assessments for suspected dementia.
o The number of patients assessed and discharged from the waiting list in the last 12 months.

Please provide this information in an electronic format (e.g., Excel or CSV) if possible.

If you consider any part of this request to be exempt, please provide reasons for your decision, including the relevant exemption clauses.

If the full information is not available, please provide what you do hold and advise how much of the requested information you are unable to supply.

I look forward to your response within 20 working days, as required under the Act.

Yours faithfully,

read more

ASD and ADHD services for children, young people, and adult

,

Good Morning,

We have recently been awarded NHS Standard Contracts to deliver ASD and ADHD services for children, young people, and adults, including diagnostic assessments and ongoing treatment where appropriate, such as medication and psychoeducation.

As a result, we’re now beginning to receive Right to Choose referrals from patients registered with GP practices in your area.

We are trying to gather as much information as possible to be proactive within our service.

We are formally asking your assistance by providing us with answers to our questions below.

1 Child ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

2 Child ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

3 Adult ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

4 Adult ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

Thanking you in advance for your assistance

with Kind regards

read more

Injuries Treated in A&E – Collision with an E-Bike / Cyclist

,

I am writing to make an application for data using the Freedom of Information Act. Please could you release the below in a “machine readable” format.

If available, please provide for me statistics for either the calendar or financial years from 2020 to 2025 (or 2020/1 to 2025/6, or as much as available for the latter).

Across the entire Trust, how many people have been treated for injuries in A&E where they have been recorded as having been involved in a collision with an e-bike (of any kind)?

If at all possible, can you say whether they were pedestrians or fellow cyclists? I am particularly interested in the former.

Please include the patient’s age, sex and whether they have any recorded disability.

Can you please break the above down for each hospital within your Trust, including if possible the date of admission and discharge.

Please include the severity of the injury (ie lower/upper limb fracture/concussion).

If available, please include how many – if any – of these culminated in a fatality.

If available, please include what type of e-bike was involved. I understand some notes have stated whether a “Lime”, “Forest”, “Human Forest” or “Tier” were involved.

If possible, please state whether the bike was moving or stationary.

On some occasions, vulnerable pedestrians, such as the blind or elderly, have tripped over badly parked e-bikes. To be able to identify such incidents would be very useful.

If there are any other details that you could include, such as a short description of any notes (without obviously revealing the injured parties identities) I would be very grateful.

I totally understand that some information may be readily available, while other elements may prove more difficult. Essentially,

I’m trying to establish how common (or not) it is for pedestrians to be injured by e-bikes. So, mere numbers will be a big help. However, the more detail you can share will help me build a more accurate picture.

I believe you have 20 working days in which to reply.

I look forward to hearing from you. If there is anything I can do to assist, please do not hesitate to contact me via email or on the number below.

Yours

read more

CIDP, Neuropathy, and GBS Diagnoses (2015–Present)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Neuropathy, and Guillain-Barré Syndrome (GBS) – 2015–Present

I am asking whether your Trust holds any activity data relating to patients who already have these diagnoses, including:

– community nursing contacts
– community therapy or rehabilitation contacts
– community outpatient episodes
– community inpatient episodes
– any other activity recorded under these conditions (if applicable)

If your Trust does not hold any activity data for patients with these conditions, please confirm this explicitly.

read more

Acupuncture Treatments / Services

I write to request the following information:

1. Does your Trust currently provide or commission acupuncture treatments or acupuncture services?

2. For each of the last five fiscal years (2020/2021, 2021/2022, 2022/23, 2023/24, 2024/25), please provide:
a. The amount spent on the provision or commissioning of acupuncture services or treatments
b. The number of patients seen by these services

Year Amount Spent Number of patients
2020/21
2021/22
2022/23
2023/24
2024/25

3. Do you currently have a contract in place with any provider for the provision of acupuncture services? If so, please provide a copy of the contract.

4. Which external organisations, charities or companies (eg the Sam Buxton Sunflower Healing Trust) have you contracted or engaged with over the provision of acupuncture services in the five fiscal years? Please include copies of any promotional materials, advertising materials or other documentation provided by the external organisation as part of this engagement

Please interpret my request in the broadest possible terms. If you have any doubt as to whether any information falls within the scope of my request, please assume that it does and include it in your response.

Yours sincerely

read more

Eating Disorder Service

I am writing to request the following information under the Freedom of Information Act 2000:
For your adult eating disorder service from January 2025-November 2025 what were the BMI of inpatients and community patients with an eating disorder at the time they were discharged?

For your adult eating disorderservice in 2025 how many inpatients and communitypatients with an eating disorderwere discharged with a BMI ofunder 15?

For your Children’s eating disorder service what was the weight for height percentage of inpatientsand community patients with an eating disorder at the time they were discharged between January 2025 and November 2025?

For your Children’s eating disorder service in 2025 how many inpatients and community patients with an eating disorderwere discharged at a weight for height of less than 75 ?

At point of discharge if patientshad a BMI of under 15, or equivalent to weight for height ofless than 75, where were yourpatients discharged to between January 2025 and November 2025? (for both adults and children)

In your adult and children’s eatingdisorder service what treatment is offered to inpatient andcommunity patients who had a BMI of under 15, or equivalent to weight for height of less than 75 between January 2025 and November 2025?

read more

Pulmonary Rehabilitation Services

,

To whom it may concern,

Under the Freedom of Information Act 2000, I am writing to request the following information regarding the commissioning and provision of pulmonary rehabilitation services within your organisation.

Please provide responses to the following for the most recent full financial year (April 2024 – March 2025).

1. Who is the person responsible for commissioning pulmonary rehabilitation services within your organisation? Please include their name, job title, and contact email if available.
2. Which provider organisations are currently delivering pulmonary rehabilitation services under contract with your organisation?
3. How many people were referred to pulmonary rehabilitation during the most recent full financial year?
4. Of those referred, how many completed a full pulmonary rehabilitation programme during the same period?
5. For which primary conditions or diagnoses do you refer patients to pulmonary rehabilitation?
6. How many individuals are currently on a waiting list for pulmonary rehabilitation, and what is the average waiting time if available?
7. What types or formats of pulmonary rehabilitation are currently offered (for example, face-to-face, home-based, or digital such as MyCOPD)?
8. What outcome measures are used to evaluate pulmonary rehabilitation services (e.g. CAT score, six-minute walk test)?

read more

Stroke Patient Clinical Data

,

Dear Freedom of Information Team

Please could I request, under the Freedom of Information Act 2000.

1. The total number of stroke patients in the Trust and the number of stroke patients in the Trust that were:

a) offered a six-month post-stroke review

and

b) had a six-month post-stroke review for each of the past 5 years, beginning with 2020.

I look forward to your reply in the statutory 20 days.

I would appreciate a reference number being provided so I can keep track of the request.

read more

Paediatric Elective Care (RTT)

, ,

Under the Freedom of Information Act 2000 I would like to request the following information.

Please provide two sets of waiting list data on paediatric elective care (RTT) (patients aged 0–17) for your Trust, disaggregated by:

1. Ethnicity (using NHS standard ethnicity categories), and
2. Indices of Multiple Deprivation (IMD) deciles or quintiles (based on patient postcode or other available proxy).

For each combination of ethnicity and IMD group, please provide the number of patients waiting in each of the following time bands:

1. Up to 18 weeks
2. 18 to 26 weeks
3. 26 to 40 weeks
4. 40 to 52 weeks
5. 52 weeks and over

Please provide this data monthly, from September 2021 to September 2025 (or the most recent available month), with each month reported separately.

If providing both ethnicity and IMD breakdowns would exceed the cost, please prioritise the ethnicity breakdown.

Please provide the data in spreadsheet format (e.g., Excel or CSV).

read more

Spinal Muscular Atrophy (SMA) Treatment

,

I would be grateful if you could please answer the following questions with regards to treatment of spinal muscular atrophy:

1. Within your Trust/ Health Board, where are patients (aged 2yrs +) with a diagnosis of Spinal Muscular Atrophy referred to for treatment?

2. How many patients with Spinal Muscular Atrophy have been referred in:

A. The last 12 months? (or the latest 12 months of data you have available)
B. The last 5 years?

Could you please split this out into SMA type if possible ( Type 0, 1, 2, 3, 4) – (see attached ICD-10 codes)

3. If your Trust/ Health Board receives referrals, where are these referrals made from?

4. How many patients return to local care for continued treatment once referred to a specialist centre?

5. If you have a treating centre for Spinal Muscular Atrophy in your trust, what is the average length of stay (or annual bed days) of patients being treated?

If you are unable to answer all of these questions, please provide answers to those that are possible to answer. Thank you for taking the time to look into this request.

read more

Hemophilia A Patients

,

1. Please provide Hemophilia A patient numbers broken down by: age, disease severity and treatment regimen (PPx denotes use for prophylaxis and OD denotes use on demand). I have proposed a format below to capture the relevant information. If data is not available by age breakdown, then please provide aggregated total in the yellow highlighted column:
July through September 2025 Age
Brand name (scientific) 0-12 years 13+
Mild Moderate Severe Mild Moderate Severe
PPx OD PPx OD PPx OD PPx OD PPx OD PPx OD
Hemlibra (emicizumab)
Altuvoct (giroctocogene fitelparvovec)
Esperoct (turoctocog alfa pegol)
Elocta (efmoroctocog alfa)
Advate (octocog alfa)
Kovaltry (octocog alfa)
Iblias (octocog alfa)
Refacto AF (moroctocog alfa)
Xyntha (moroctocog alfa)
NovoEight (turoctocog alfa)
Nuwiq (simoctocog alfa)
Vihuma (simoctocog alfa)
Inhibitor patients
2. For Hemlibra-treated Hemophilia A Inhibitor patients, please indicate the number of patients by age group and dosing frequency for Q3’25 (July–September 2025). If data is not available by age breakdown then please provide aggregated total:
Age group (Hemophilia A inhibitor patients) Once weekly Every 2 weeks Every 4 weeks
0-12 years
13+ years
Total
Non-inhibitor patients
3. For Hemlibra-treated Hemophilia A non-inhibitor patients, please indicate the number of patients by age group and dosing frequency for Q3’25 (July–September 2025). If data is not available by age breakdown then please provide aggregated total:
Age group (Hemophilia A non-inhibitor patients) Once weekly Every 2 weeks Every 4 weeks
0-12 years
13+ years
Total

read more

Non-Pharmacological ADHD Interventions for Children

Subject: Freedom of Information Request – Non-Pharmacological ADHD Interventions for Children

Dear FOI Officer,

I am writing to request information under the Freedom of Information Act 2000 regarding the provision of non-pharmacological interventions for children and young people with Attention Deficit Hyperactivity Disorder (ADHD) within your Trust. To help me understand your service model, I would be grateful if you could provide responses to the following:

1. Service Provision
• – Do you provide non-pharmacological interventions for children and young people diagnosed with ADHD?
• – If so, please list the types of interventions offered (e.g., parent training, CBT, psychoeducation, skills groups, school liaison, peer support, digital interventions, etc.).
• – Are these delivered by your Trust directly, jointly with external providers, or commissioned from other organisations?
• With what frequency are patients/families offered these sessions?
• How many sessions are offered to patients/families or at what point is intervention ceased?

2. Referral & Access
• – At what stage of the care pathway are non-pharmacological interventions offered (e.g., pre-diagnosis, post-diagnosis, alongside medication, instead of medication)?
• – What are the eligibility criteria (if any) for accessing these interventions?

3. Workforce & Delivery
• – Which professional groups deliver these interventions (e.g., psychologists, nurses, occupational therapists, social workers, peer support workers)?
How many WTE (whole time equivalent) staff are currently employed in delivering ADHD-related non-pharmacological interventions?

4. Capacity & Outcomes
• – Approximately how many children/young people accessed these interventions in the last financial year (April–March)?
• – Do you collect outcome measures for these interventions? If yes, please specify which tools or measures are used (e.g., SDQ, SNAP-IV, goal-based outcomes, parent/carer feedback, etc.).

5. Commissioning & Funding
• – Are these interventions funded within core CAMHS/neurodevelopmental services, or separately commissioned?
• – Has your Trust secured any additional funding streams (e.g., NHS Long Term Plan, local authority joint commissioning) to support delivery?

6. Future Planning
• – Are there plans to expand, reduce, or change the provision of non-pharmacological ADHD interventions for children in the next 2 years?

Notes

– Please provide the information in electronic format (Word, Excel, or PDF).
– If the information requested exceeds the cost/time limit, please advise which elements could be prioritised.
– If you do not hold the information, please confirm whether another organisation may be responsible.

Thank you for your assistance. I look forward to your response within the statutory 20 working days.

read more

Adult Deaf Sign Language Users

,

The lifetime prevalence of mental disorder in the general population is 1 in 4. For profoundly deaf people this approaches 1 in 2 yet the number of deaf adults accessing mental health services is very low.

The National Deaf Mental Health Service supports Deaf BSL users across the middle third of England.

We have seen a fall in referrals for community and inpatients in recent years.

We are keen to know if there are people accessing local services who may not have been considered for referral to specialised services.

I would be grateful if you could provide the number of adult deaf sign language users who are have been inpatients within your Trust over the last 5 years.

Please could you provide the number of adult Deaf sign language users currently on the community caseload of the Trust.

Please provide the number of adult Deaf sign language users supported by the trust community services in the last 5 years.

read more

Contraceptive Implants

Dear Sir/Madam,

This is a Freedom of Information Act request. I would like to know the following information:
• How many children (under 18s) have been given the contraceptive implant for each of the last five calendar years (2021, 2022, 2023, 2024 and 2025 so far)?
• Please provide a breakdown by age of all children given the contraceptive implant for each of the last five calendar years (2021, 2022, 2023, 2024 and 2025 so far).
• Please consider all ages from the youngest person given the implant up to and including those given the implant aged 17. For the answer to this question, a table like this may help illustrate the information I am asking for:
•
Age 9 10 11 12 13 14 etc up to 17
2021
2022
2023
2024
2025 so far

I look forward to a response within 20 working days. Please contact me on this email address if you have any queries.

read more

Slips, Trips and Falls in Home Bathrooms

Dear FOI Officer,

I am writing to request information under the Freedom of Information Act 2000.
Please could you provide the following information:

1. 1. The total number of recorded incidents of slips, trips, and falls in home bathrooms involving patients within your Trust/Health Board for each calendar year from 2020 to September 2025.

2. 2.If available, a breakdown of these figures by:

a. Age groups (50–59, 60–69, 70–79, 80–99, 100+)
b. Gender (Male, Female)

If any part of this request is unclear or would exceed the cost limit, please provide advice and assistance as required by Section 16 of the FOI Act.

I look forward to your response within the statutory 20 working days.

Please provide the data in an electronic format if possible.

Best wishes,

read more

Mental Health Waiting Times

,

Under the Freedom of Information Act 2000, I would like to request the following information:
1. The current average waiting time for patients to access your mental health services.
2. The total number of patients currently on waiting lists for mental health services.
Please provide the most recent figures you hold (as of September 2025), ideally in spreadsheet format (Excel/CSV).

read more

Miscarried Babies which have been lost, discarded or contaminated

Dear the Gloucestershire Health and Care NHS Foundation Trust,

I hope you are well.

I’m a reporter for the Colchester Gazette and Newsquest.

I am writing to request information under the Freedom of Information Act 2000. I would like to obtain the following information:
• The number of miscarried babies that were reported as discarded, lost, or contaminated in the Gloucestershire Health and Care NHS Foundation Trust for the past five years.
• A breakdown of these incidents by year
• A breakdown of any costs due to these incidents
• A breakdown of hours spent by NHS workers either attempting to find or reporting or spending time on these incidents

This FOI follows this article https://www.gazette-news.co.uk/news/25393764.essex-womans-miscarried-baby-lost-hospital-contaminated/.

Please provide this information in an electronic format. If this request is too broad or unclear, I would be grateful if you could contact me to provide advice and assistance on how to refine it.

I am also contacting other NHS trusts across the United Kingdom.

Thank you for your time and assistance.

read more

Respiratory Physiology – Sleep Studies figures

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to request the following information under the Freedom of Information Act.

The total number of Respiratory Physiology – Sleep Studies (10) performed in each of the respective financial years 2019/20, 2020/21, 2021/22, 2022/23, and 2023/24.

If the full dataset is not available, please supply the information you hold and advise how I might obtain the remainder.

read more

Prescriptions Issued for Sleep Medication in the UK

We’re looking to conduct FOI requests with NHS trusts regarding prescriptions issued for sleep medications in the UK. For example, how many prescriptions were issued for sleep medications (e.g. Zopiclone, melatonin) in the last 5 years
• Total number of sleep disorders recorded in the last five years (broken down by year) and split by age range – I have attached a spreadsheet with the full list.
• The total number of drug prescriptions issued for the following sleep disorders in the past five years (broken down by year and by drug type e.g. Melatonin, Benzodiazepines, Z-drugs)
• The total number of patients referred to non-drug treatments, such as CBT-I

read more

Radiology Reporting Services

Please could you provide the following information: General Information

1. The total number of radiology scans performed at NHS hospitals in the last 12 months, broken down by modality (CT, MRI, and nuclear medicine scans).
2. A detailed breakdown of the scans performed by body part for each of the above modalities (For example CT head, MRI Spine, bone scan etc) at each trust.
3. The total number of outsourced scans for reporting purposes, categorized by modality (CT, MRI, and nuclear medicine) for each hospital / trust. Outsourcing and Teleradiology
4. Whether any radiology scans are outsourced to external providers by the hospitals.
5. The percentage of scans outsourced for each modality, if applicable at each hospital.
6. The names of the external providers contracted for outsourced radiology reporting to each NSH hospital.
7. The cost per scan for outsourced services, broken down by modality and body part. Financial Information
8. The total expenditure on outsourced radiology reporting services in the last financial year per trust.
9. Whether there are fixed pricing agreements between teleradiology providers and the hospitals, and if so, the details of these agreements to include start and finish dates and the cost in pounds. Contracts and Agreements
10. Any active contracts the hospitals have with teleradiology companies, including: a. The names of the contracted providers. b. The start and end dates of the contracts. c. The performance or quality metrics outlined in the contracts. Backlogs and Reporting Times
11. The current backlog for radiology scan reporting, broken down by modality and body part at each NHS trust.
12. The average reporting time for in-house radiology scans, categorized by modality.
13. The average reporting time for outsourced scans.
14. Whether specific modalities or body parts have more significant backlogs. Additional Details
15. Any delays in reporting radiology scans over the last 12 months and the primary causes of such delays.
16. Whether the hospital has plans to reduce reliance on outsourcing for radiology reporting, and if so, the details of these strategies.

read more

ECT Treatment – 2025

Dear Sir/Madam,

I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).

The information being requested is as follows:

1. Please provide the number of ECT treatments given to patients in the year 2025 to date (with the date range this applies to)

2. Please provide the number of patients having received ECT treatment in the year 2025 to date (with the date range this applies to)

I look forward to hearing from you in due course.

read more

Bronchiectasis – CT Scan Referrals

Good afternoon,
After extensive research, we have been unable to find the following data, and I would now like to request it from you.
Please can I request the number of CT scans referred from primary care for SCITID 12295008 Bronchiectasis, and if you have open access to CT scans from primary care.
Best wishes,

read more

Mortuaries – NHS Trusts

,

Dear NHS Trust officers,

I’m writing to request some information under the Freedom of Information Act.

For each month in the past 2 years (Aug 2023 – Aug 2025), please let me know:
1) the Number of people’s bodies that were moved between hospitals’ mortuaries
2) the Median and Maximum number of days for a body to be released from a hospital mortuary to a funeral director

Please provide such data electronically, ideally as a spreadsheet.

read more

Myeloma Patients

To whom it may concern, I am writing to you under the Freedom of Information Act 2000 on behalf of Myeloma UK to request the following information: 1. Is your health trust currently treating myeloma patients 2. Please list the hospitals in your board/trust that are currently treating myeloma patients. 3. Please list how many myeloma patients are being treated by your board/trust. Please break this down by hospital. 4. Is your health trust currently treating myeloma patients with elranatamab or teclistamab. Please break this down by hospital. 5. Please list how many people have been given a) elranatamab or b) teclistamab since approval by the National Institute of Health and Care Excellence in 2024 (TA1023 and TA1015. If possible, please break this down by hospital. 6. Do you have a service level agreement or referral system in place with any other health trusts to deliver a) elranatamab or b) teclistamab to patients. If the answer this question is yes, which health boards / trusts do you have an agreement in place with. If you have any queries, please don’t hesitate to contact me via e-mail. Thank you for your time and I look forward to your response.

read more

Current use of Moreton Clinic Space (18/09/2025)

I keen to understand how much use the Acute Trust specialists are able to make of the Outpatient clinic facilities in Gloucestershire’s Community Hospitals. I am particularly interested in to know what Acute Trust services are provided at Moreton Community Hospital, although the question is also relevant to all of Gloucestershire’s Community Hospitals.

I believe that prior to the Pandemic good use of Moreton’s clinic space by Acute Trust Consultants etc was made, but that now clinics are few and far between – physio, orthoptists, hearing aid support. Your website suggests that clinics are held in response to demand. What constitutes “demand”?
Given the Secretary of State’s wish to move more specialist provision into the community, it would be helpful to know to what extent that already happens in our Community Hospitals, and what are the issues that prevent greater use. I guess that cost is a major block to greater use – but who bears what cost (GHC? GHT? ICB?)

As background, I am a retired GP and am currently a Public Governor at Gloucestershire Hospitals Trust. This issue has recently been raised with me by PPG members from North Cotswolds GP Practices. Residents in that area have long journey times to and from GRH or CGH, and are increasingly frustrated that OP clinics appear not to be held in the excellent facility at Moreton and elsewhere. I have family living in North Cotswolds too and understand their frustrations.

Would it be possible to provide me with a timetable of current use of Moreton clinic space, or would that need to go through FOI channels?

read more

Air Pollution Exposure

Please provide the following information, broken down by month, between January 2020 and July 2025 inclusive. If this is not possible, please instead provide it broken down by calendar year, 2020 to 2025 inclusive.

1. The number of times a patient was admitted where exposure to air pollution (International Classification of Diseases, tenth revision (ICD-10) code Z581)* was recorded as a contributing factor to the admission.
(* I understand this is the code used by NHS trusts to log exposure to air pollution, but if your trust uses a different code or some other system, please still provide the relevant data)

1a. If possible, please tell me what the primary diagnosis was for each of these admissions.
(For clarity, I want to know total numbers admitted with each primary diagnosis — for example, if 45 people were admitted with a primary diagnosis of asthma where exposure to air pollution was identified as a contributing factor.)

2. Please tell me how many of the patients in question 1 subsequently died in hospital.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you can identify any ways that my request could be refined I would be grateful for any further advice and assistance.

If you are able to supply some of this information more quickly than other items, please supply each item when you can rather than delay everything until it is all available.

read more

Out of Area Placements – 2019 to 2025

I’d like to make the following request under the freedom of information act.
Could you tell me, for 2019-2025
a) how many patients were transferred out-of-area
b) the furthest distance a patient was transferred
c) the longest period a patient was placed in an out-of-area trust

read more

Management Pathway of Elderly Patients – Emergency Departments

Dear colleagues,

We are undertaking a survey regarding the management pathway of elderly patients (>65 years old) presenting with trauma in the Emergency Department.

I am emailing you to a make freedom of information request with regard to trauma protocols for silver trauma patients. We would like to know the following information if available:

. Does your hospital have a guideline for silver trauma patients (>65 years old) attending ED?

. What are the ED’s indications for initiating a silver trauma call and requesting a trauma CT for elderly patients at your hospital?

· Which specialties are called for silver trauma in ED? Does it include General surgery, Orthopaedics, Anaesthetics and Medicine of the elderly?

· Does your hospital have a guideline for assessing delirium in silver trauma patients (>65 years old)?

· Do all the silver trauma patients get reviewed by medicine of the elderly on the ward if admitted? · Do you have a guideline for assessment of the silver trauma patients on the ward by medicine of the elderly?

· Can you please attach your hospital’s guidelines for silver trauma patients in your reply?

Thank you for your help! Looking forward to your response.

Please do not include any patient confidential information in your response.

read more

Patient Attending A & E regarding Carbon Monoxide

Dear FOI Officer, I am writing to request information, under the Freedom of Information Act 2000, regarding carbon monoxide (CO) cases in relation to research for Project SHOUT.

Could you please provide the following information, from the Gloucestershire Health and Care NHS Foundation Trust, for the periods: 1st August 2018 to 31st July 2019:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over 1st August 2019 to 31st July 2020:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old 2.

Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over 1st August 2020 to 31st July 2021:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over 1st August 2021 to 31st July 2022:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over 1st August 2022 to 31st July 2023:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over 1st August 2023 to 31st July 2024:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old

2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over 1st August 2024 to 31st July 2025:

• The total number of carbon monoxide (CO) cases that attended A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over

• The total number of carbon monoxide (CO) cases that were treated at A&E

1. Of the total figure, how many were aged 0-18 years old 2. Of the total figure, how many were aged 60 years old and over If possible.

I would be grateful to receive this information in an Excel spreadsheet format.

read more

Inclusive Community and Elective Care Waiting Lists

Under the Freedom of Information Act 2000 I would like to request the following information.

This request relates to NHSE’s July 2025 time-series elective care waiting list release from September 2021-June 2025 which disaggregated data by age and sex and partially disaggregated by ethnicity and Indexes of Multiple Deprivation (IMD). Please provide the requested information in an Excel spreadsheet.

1. Share the paediatric elective care waiting list data (under 18) disaggregated by ethnicity and IMD for the time-series September 2021-June 2025, displayed as total numbers waiting month by month. Please indicate if this data has not been collected.

2. Share paediatric community service waiting list data (under 18) disaggregated by ethnicity and IMD for the time-series September 2021– June 2025, displayed as total numbers waiting month by month. If this data has not been collected, please provide the total waiting list for paediatric community care between September 2021-June 2025 by month.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you have any queries, please don’t hesitate to contact me via email and I will be happy to clarify. Thank you for your time and I look forward to your response.

read more

Transcranial Magnetic Stimulation Funding

Hi. Thank you for responding to the FOI below. I have a few follow up questions.

1. How many patients have had TMS funded by GHC in the last 24 months.

2. Could you give an estimate on total expenditure on TMS in last 24 months.

3. What providers (NHS or private) have delivered TMS funded by GHC.

read more

Methotrexate Level Monitoring – Patients receiving Methotrexate

I am writing to submit a request for information under the Freedom of Information Act 2000.

I would be grateful if you could provide information regarding your hospitals clinical practice on the timing of methotrexate (MTX) level monitoring in patients receiving high-dose methotrexate (HDMTX) therapy. Specifically, I am seeking the following:

Adult Patients
1. For adult patients with acute lymphoblastic leukaemia (ALL) receiving HDMTX, at what time point does your centre take the first MTX level?
2. For adult patients with osteosarcoma receiving HDMTX, at what time point does your centre take the first MTX level?
3. For adult patients with non-Hodgkin’s lymphoma receiving HDMTX, at what time point does your centre take the first MTX level?

Paediatric Patients
1. For paediatric patients with acute lymphoblastic leukaemia (ALL) receiving HDMTX, at what time point does your centre take the first MTX level?
2. For paediatric patients with osteosarcoma receiving HDMTX, at what time point does your centre take the first MTX level?
3. For paediatric patients with non-Hodgkin’s lymphoma receiving HDMTX, at what time point does your centre take the first MTX level?

Please note that I am not requesting any patient-specific data. This request relates solely to your clinical practice guidelines or standard protocols.

read more

Consultant-Led Planned Hospital Treatment – Waiting Lists

Please can you tell me:

1. The number of patients who have died while on your waiting list to recieve consultant-led elective (planned) hospital treatment — and who have therefore been removed from the list due to to their death or status as being deceased — between January 1 2025 and July 31 2025?
(If your trust calls this particular waiting list something else, please use common sense and provide the waiting list data most relevant to my questions.)

1a. If possible, please tell me how many of these people who died had been waiting for longer than 18 weeks since being referred for consultant-led elective hospital treatment?

1b. If possible, please provide a seperate breakdown of the ethnicity and religion of all those who died while on this your waiting list to recieve consultant-led elective (planned) hospital treatment over this time period.

2. The number of patients who have died while on your waiting list to recieve consultant-led elective (planned) hospital treatment — and who have therefore been removed from the list due to to their death or status as being deceased — broken down into the years 2024, 2023, 2022, 2021 and 2020, please.

2a. If possible, please provide a seperate breakdown of the ethnicity and religion of those who died while on you waiting list for consultant-led elective (planned) hospital treatment in each of these years.

If you are encountering any practical difficulties with complying with this request, please contact me as soon as possible (in line with your duty under section 16 to advise and assist requesters), so that we can discuss the matter and if necessary I can modify the request.

If you are able to supply some of this information more quickly than other items, please supply each item when you can rather than delay everything until it is all available.

Please format this data clearly and provide it in a machine readable format (such as xslx).

read more

ECT, Seclusion, Restrains, Medication Errors

,

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: –
1.Please supply patient’s information ECT leaflet
2.Please supply patient ECT consent form
3.Please supply any ECT reports/investigations
4.How many ECT in 2024?
5.What proportion of patients were men/women?
6.How old were they?
7.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
8.How many people covered by the equality act – specific protected characteristics – excluding age + gender – received ECT ?
9.How many people were offered talking therapy prior to ECT ?
10.How many were receiving ECT for the first time?
11.How many patients consented to ECT?
12.How many ECT complaints were investigated outside the NHS ?
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?
16.How many patients have suffered complications during and after ECT and what were those complications?
17.Have there been any formal complaints from patients/relatives about ECT?
18.If so, what was their concerns?
19.How many patients report memory loss/loss of cognitive function?
20.What tests are used to assess memory loss/loss of cognitive function?
21.Have MRI or CT scans been used before and after ECT?
22.If so, what was the conclusion?
23.How does the Trust plan to prevent ECT in the future?

Please provide restraints information under the FOI act to the following questions: –
1.Please supply any Restraints/investigations
2.How many RESTRAINTS in 2024?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were restrainted?
7.How many RESTRAINTS were investigated outside the NHS?
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?
12.Have there been any formal complaints from patients/relatives about RESTRAINTS?
13.If so, what was their concerns?
14.Are counts of forced injections available? if so how many people were forcible injected ?
15.How does the Trust plan to reduce restraints in the future?
16.How many of these restraints were face down restraints?

Please provide SECLUSION information under the FOI act to the following questions: –
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2024?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were secluded ?
7.How many SECLUSIONS were investigated outside the NHS?
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
11.How many patients have suffered complications during and after SECLUSION and what were those complications?
12.Have there been any formal complaints from patients/relatives about SECLUSION?
13.If so, what was their concerns?
14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: –
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2024?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – endured medication errors ?
7.How many MEDICATION ERRORS were investigated outside the NHS ?
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?
13.If so, what was their concerns?
14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

read more

Minor Injuries Wait

, ,

I am writing to update and clarify my request for information under the Freedom of Information Act 2000.
The purpose of this request is to gather data on overnight Minor Injuries wait times within the trust.
Specifically, I am seeking anonymised data on the following:
1. How many patients in Minor Injuries waited 24 hours or more from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
2. How many patients in Minor Injuries waited for 3 hours or more between the hours of 11pm-6am from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
3. The average Minor Injuries wait time from time of arrival until admission to hospital or discharge for each of the past five calendar years 2020, 2021, 2022, 2023, 2024 and partial data for 2025 if available
If you are unable to provide the specified information:
• If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.
• If you are unable to provide the specified information exactly as requested, please provide *any* data you have that is relevant to the request, e.g. 2024 only, and explain why the other information cannot be provided.

read more

Dravet Syndrome and Lennox-Gastaut Syndrome/Treatments

I would like to submit an FOI request for the following data for Gloucestershire Health and Care NHS Foundation Trust:
1. The number of unique patients with a recorded diagnosis of Dravet syndrome in 2024-2025. Likely coded as ICD-10 code G40.3 or SNOMED code of 230437002, ideally separated by month.
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
2. The number of unique patients with a recorded diagnosis of Lennox-Gastaut syndrome in 2024-2025. Likely coded as ICD-10 code G40.4 or SNOMED code of 230418006, ideally separated by month.
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
3. The number of unique patients who have been treated with fenfluramine in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside fenfluramine, and indicate the number of patients receiving each
4. The number of unique patients who have been treated with cannabidiol in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside cannabidiol, and indicate the number of patients receiving each
5. The number of unique patients who have been treated with cenobamate in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside cenobamate, and indicate the number of patients receiving each
6. The number of unique patients who have been treated with rufinamide in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside rufinamide, and indicate the number of patients receiving each
7. The number of unique patients who have been treated with stiripentol in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside stiripentol, and indicate the number of patients receiving each
8. The number of unique patients who have been treated with clobazam in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside clobazam, and indicate the number of patients receiving each
9. The number of unique patients who have been treated with sodium valproate in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside sodium valproate, and indicate the number of patients receiving each
10. The number of unique patients who have been treated with levetiracetam in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside levetiracetam, and indicate the number of patients receiving each
11. The number of unique patients who have been treated with topiramate in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
18 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside topiramate, and indicate the number of patients receiving each
12. The number of unique patients who have been treated with lamotrigine in 2024-2025, separated by month
Patient numbers segmented by age:
0-3 years old
4-8 years old
9-18 years old
8 years+
For these patients, how many of them had a diagnosis of:
Dravet Syndrome (ICD10 Code: G40.3) SCTID: 230437002
Lennox-Gastaut syndrome (ICD10 Code: G40.4) SCTID: 230418006
For these patients, please provide a detailed breakdown of concurrent treatments. Specifically, list each additional treatment received alongside lamotrigine, and indicate the number of patients receiving each

read more

Invasive Procedure Data Capture

Under the Freedom of Information Act 2000, I would like to request information regarding clinical documentation practices, specifically in relation to the capture of information during interventional procedures, such as Central Venous Access Device (CVAD) insertions.

1. Clinical Documentation
• What methods are currently used by clinicians to document key information during invasive procedures, such as CVAD insertions (e.g., paper forms, digital forms, voice dictation, other)?
o Is any form of structured digital data entry used at the point of care for these procedures?
• Are standardised templates or proformas used Trust-wide for documenting invasive procedures, such as Local Safety Standards for Invasive Procedures (LocSSIPs)?
o Are any of these LocSSIPs or other forms digitised?

2. Voice Technology
• Does the Trust currently use any voice-to-text or voice recognition technology for clinical documentation (e.g., Dragon Medical One, Nuance, Voice-Care, etc.)?
• If yes, which departments or specialties currently use it, and for which types of documentation?

3. Administrative Efficiency
• Has the Trust undertaken any assessments of the administrative time burden associated with completing procedural documentation (manual or digital)?
o If so, is any information available on time spent per procedure or efforts to streamline the process?

4. Future Plans
• Is the Trust currently planning any initiatives or procurements to digitise documentation processes for interventional procedures?
o If yes, please outline the scope and timelines if available.

read more

Hip Fractures at Minor Injuries Department

I am writing under the Freedom of Information Act 2000 to request information relating to the diagnosis and treatment of hip fractures for patients presenting at your Minor Injuries department, broken down by year, for the past four calendar years (2021, 2022, 2023, 2024) up to and including 03 May 2025:

· The number of patients who presented at Minor Injuries with hip pain and were referred for: X-Ray o MRI scan.

· Of those who underwent an X-ray only, how many had negative or inconclusive results but were later diagnosed with a femoral neck or other hip fracture?

If the request exceeds the cost exemption, as per s12 of the 2000 Act, please advise me on how to amend my request accordingly.

read more

Wait Times and Repeat Referrals

I am submitting this request under the Freedom of Information Act 2000. Please provide the following information:

1. Longest wait times for therapy services. Please provide the longest recorded wait times for local NHS Talking Therapies in 2024.
2. Percentage of patients waiting more than 90 days for their first completed appointment.
3. Repeat referrals within 12 months of discharge. Please provide the number of patients who were discharged from local NHS Talking Therapies but required a repeat referral within 12 months in 2024.
4. Total referrals for local NHS Talking Therapies in the 2024 calendar year.
In the event you can’t respond to all four questions please answer as many as possible taking each in turn, 1-4.

read more

Cancer Treatment

I would be grateful if you could please answer the following question with regards to cancer treatment:

In the last 12 months, how many unique patients in your trust have been treated privately for the following ICD-10 codes?

A) C61 Malignant neoplasm of prostate
B) C16.0 Malignant neoplasm of the gastroesophageal Junction

read more

Admissions Involving the Insertion of Objects

I am writing to request the following information under the Freedom of Information Act:

For the period from January 2019 to the most recent available data, please provide the following details relating to admissions involving the insertion of objects into the anus or vagina.

• The total number of incidents recorded per year.
• The age and gender of the individual involved in each incident (if available and anonymised).
• A brief description of the incident or nature of injury and if the insertion was accidental or deliberate (if available and anonymised).
• The item used – including but not limited to sex toys, household objects, and food.

read more

Colposuspension – Management of Urinary Incontinence in Women

I am conducting a research project to compare the safety and efficacy of permanent versus absorbable sutures in Colposuspension for the management of stress urinary incontinence in women. I would be grateful if you could help me with this data.

From your hospital surgical database, please can you provide us with:
1. the number of Colposuspensions conducted in your unit between January 2020 and January 2025.
Of these, please clarify how many were conducted:
-open
-laparoscopically
-robotically

2. How many of these cases have needed to go back to theatre for any procedure under the care of urogynaecology/gynaecology/urology since the initial operation?
Please state, what procedures they then underwent.

The following questions, may be known by the theatre team via the surgeon’s cardex (information sheet which each surgeon will have with their preference of equipment for each operation) for Colposuspension. In the worst case, it may need to posed to the surgeons who usually perform colposuspensions but should be a quick answer:

“Which suture material is routinely used to suture onto the iliopectineal ligament in open cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

“Which suture material is routinely used to suture onto the iliopectineal ligament in laparoscopic cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

“Which suture material is routinely used to suture onto the iliopectineal ligament in robotic cases? Please state name of suture or N/A if this route of colposuspension is not performed.”

read more